Atropos Health and Guidehouse have launched a jointly developed clinical decision support (CDS) solution designed to integrate real-world evidence (RWE) directly into clinical workflows for healthcare teams and life sciences organizations.
The new solution combines Atropos Health’s predictive analytics and evidence generation capabilities with Guidehouse’s expertise in commercialization, medical strategy, and market access. The platform is designed to help life sciences companies translate data-driven insights into actionable decisions at the point of care.
Built using predictive algorithms and real-world data, the CDS solution embeds evidence-based insights directly into electronic health record (EHR) systems. The platform enables healthcare providers to identify relevant patients, support diagnosis and treatment decisions, and optimize care pathways through in-workflow alerts and insights.
Click here to join our WhatsApp channel here
The solution also helps identify underdiagnosed or undertreated patients while supporting earlier intervention and treatment optimization with minimal disruption to provider workflows.
Dr. Brigham Hyde CEO and co-founder of Atropos Health. said, “Partnering with Guidehouse marks a pivotal moment in our mission to bring real-world evidence to the forefront of clinical and commercial decision making. Together, we can deliver AI-driven insights at a scale and speed the pharmaceutical industry has never seen before helping get the right treatments to the right patients faster, with a goal to ultimately save lives.”
For life sciences organizations, the platform is intended to bridge the gap between evidence generation and real-world clinical impact by supporting compliant medical and commercial strategies, improving treatment decisions, and enhancing engagement across healthcare systems.
Also read: Mediclinic Middle East and MetLife partner to deliver nationwide access to virtual care
Jacob Graham Partner, Life Sciences, at Guidehouse said, “Our CDS solution reflects a shift from insight generation to insight deployment. By combining Atropos Health’s predictive modeling and evidence capabilities with Guidehouse’s experience operationalizing solutions in the market, we are helping clients embed real-world evidence into care delivery in a way that drives measurable clinical and commercial impact.”
